Dimensional Fund Advisors LP Cuts Position in Elevance Health, Inc. $ELV

Key Points

• Dimensional Fund Advisors LP trimmed its stake in Elevance Health by 0.5%, selling 8,756 shares to finish the quarter with 1,668,883 shares (about 0.75% of the company, valued at roughly $539.2 million); institutional investors own ~89% of ELV.
• Elevance beat quarterly EPS expectations ($3.33 vs. $3.10) while reporting $49.31 billion in revenue (slightly below estimates) and 9.6% year‑over‑year revenue growth; the stock carries a consensus rating of Moderate Buy with an average price target of $390.55.
• Elevance raised its quarterly dividend to $1.72 (annualized $6.88), a ~2.4% yield; the ex‑dividend date is March 10 and the payment date is March 25.

Dimensional Fund Advisors LP reduced its position in Elevance Health, Inc. (NYSE:ELV - Free Report) by 0.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,668,883 shares of the company's stock after selling 8,756 shares during the quarter. Dimensional Fund Advisors LP owned 0.75% of Elevance Health worth $539,189,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ELV. Physician Wealth Advisors Inc. lifted its holdings in shares of Elevance Health by 331.6% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company's stock worth $26,000 after acquiring an additional 63 shares during the last quarter. Activest Wealth Management lifted its position in Elevance Health by 66.7% in the third quarter. Activest Wealth Management now owns 85 shares of the company's stock valued at $27,000 after purchasing an additional 34 shares during the last quarter. Rossby Financial LCC boosted its stake in shares of Elevance Health by 110.0% during the third quarter. Rossby Financial LCC now owns 84 shares of the company's stock valued at $28,000 after purchasing an additional 44 shares during the period. Vermillion & White Wealth Management Group LLC boosted its stake in shares of Elevance Health by 94.9% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company's stock valued at $30,000 after purchasing an additional 37 shares during the period. Finally, BOK Financial Private Wealth Inc. bought a new position in shares of Elevance Health in the second quarter worth approximately $32,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ELV shares. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $332.00 price target on shares of Elevance Health in a report on Thursday, January 29th. Morgan Stanley decreased their price objective on shares of Elevance Health from $359.00 to $352.00 and set an "equal weight" rating on the stock in a research report on Wednesday, December 17th. UBS Group set a $400.00 target price on shares of Elevance Health in a report on Thursday, January 29th. Wells Fargo & Company cut their target price on Elevance Health from $424.00 to $391.00 and set an "overweight" rating on the stock in a research note on Friday, January 30th. Finally, Royal Bank Of Canada downgraded Elevance Health from an "outperform" rating to a "sector perform" rating and set a $358.00 price target on the stock. in a report on Tuesday, February 3rd. Twelve equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $390.55.

Elevance Health Price Performance

ELV stock opened at $291.46 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.54. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75. The firm has a 50-day moving average of $346.99 and a 200 day moving average of $335.49. The company has a market cap of $64.33 billion, a P/E ratio of 11.60, a PEG ratio of 1.57 and a beta of 0.51.

Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.10 by $0.23. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The business had revenue of $49.31 billion for the quarter, compared to analysts' expectations of $49.52 billion. During the same period in the previous year, the firm posted $3.84 EPS. The business's revenue was up 9.6% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, sell-side analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Tuesday, March 10th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 2.4%. This is a positive change from Elevance Health's previous quarterly dividend of $1.71. The ex-dividend date is Tuesday, March 10th. Elevance Health's dividend payout ratio is currently 27.23%.

About Elevance Health

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.